These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26638682)

  • 1. Alzheimer's Disease: An Exacerbation of Senile Phenoptosis.
    Isaev NK; Stelmashook EV; Genrikhs EE; Oborina MV; Kapkaeva MR; Skulachev VP
    Biochemistry (Mosc); 2015 Dec; 80(12):1578-81. PubMed ID: 26638682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria in aging and Alzheimer's disease.
    Crouch PJ; Cimdins K; Duce JA; Bush AI; Trounce IA
    Rejuvenation Res; 2007 Sep; 10(3):349-57. PubMed ID: 17708691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of oxidative stress in brain aging and Alzheimer's disease.
    Ionescu-Tucker A; Cotman CW
    Neurobiol Aging; 2021 Nov; 107():86-95. PubMed ID: 34416493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional neurocognitive data do not support a transition from fibrofog to Alzheimer disease in fibromyalgia patients.
    Leavitt F; Katz RS
    J Clin Rheumatol; 2015 Mar; 21(2):81-5. PubMed ID: 25710859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mouse models of brain ageing and Alzheimer's disease.
    Bilkei-Gorzo A
    Pharmacol Ther; 2014 May; 142(2):244-57. PubMed ID: 24362083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C; Holsboer F
    Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SkQ1 as a Tool for Controlling Accelerated Senescence Program: Experiments with OXYS Rats.
    Kolosova NG; Kozhevnikova OS; Muraleva NA; Rudnitskaya EA; Rumyantseva YV; Stefanova NA; Telegina DV; Tyumentsev MA; Fursova AZ
    Biochemistry (Mosc); 2022 Dec; 87(12):1552-1562. PubMed ID: 36717446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altering mitochondrial dysfunction as an approach to treating Alzheimer's disease.
    Colca JR; Feinstein DL
    Adv Pharmacol; 2012; 64():155-76. PubMed ID: 22840747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder.
    Sultana R; Mecocci P; Mangialasche F; Cecchetti R; Baglioni M; Butterfield DA
    J Alzheimers Dis; 2011; 24(1):77-84. PubMed ID: 21383494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic psychological distress and risk of Alzheimer's disease in old age.
    Wilson RS; Arnold SE; Schneider JA; Kelly JF; Tang Y; Bennett DA
    Neuroepidemiology; 2006; 27(3):143-53. PubMed ID: 16974109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
    Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
    Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens and Alzheimer's disease.
    Drummond ES; Harvey AR; Martins RN
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):254-9. PubMed ID: 19373081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mitochondrial dysfunction in Alzheimer's disease.
    Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of neuroprotection on incidence of Alzheimer's disease.
    de la Fuente-Fernández R
    PLoS One; 2006 Dec; 1(1):e52. PubMed ID: 17183682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer's disease and depression].
    Gallarda T
    Encephale; 1999 Nov; 25 Spec No 5():14-7; discussion 18. PubMed ID: 10609097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease: a lesson from mitochondrial dysfunction.
    Moreira PI; Santos MS; Oliveira CR
    Antioxid Redox Signal; 2007 Oct; 9(10):1621-30. PubMed ID: 17678440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.